6.48 (0.812%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Weak
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
argenx SE Sponsored ADR
Telephone
31.76.303.04.88
Address
Laarderhoogtweg 25, Amsterdam, Noord-Holland 1101 EB
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 510.05 - 934.62
Trade Value (12mth)
US$67,373,274.00
1 week
-0.19%
1 month
-0.94%
YTD
-5.03%
1 year
36.38%
All time high
934.62
EPS 3 yr Growth
-262.00%
EBITDA Margin
24.50%
Operating Cashflow
$850m
Free Cash Flow Return
13.20%
ROIC
20.10%
Interest Coverage
249.60
Quick Ratio
4.90
Shares Outstanding (Fully Diluted)
66m
HALO Sector
Healthcare
Next Company Report Date
04-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 11 May 26 | |
| 07 May 26 | |
| 07 May 26 | |
| 20 April 26 | |
| 21 March 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -5.17 | 13.89 | 21.14 | | | | ||
EPS (Fully Diluted) | $ | | | | | -5.17 | 12.76 | 19.63 | | | | ||
Growth | % | | | | | 60.4 | 368.8 | 52.2 | | | | ||
PE | X | | | | | N/A | 44.3 | 39.8 | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | 50 | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
